IDEXX Laboratories, Inc. Share Price
Stocks
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
01:30:00 14/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 520.31 USD | -0.69% |
|
+0.95% | -23.09% |
| 12/10 | KeyBanc Initiates IDEXX Laboratories at Sector Weight | MT |
| 01/10 | IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI | MT |
| Market Cap | 4.1TCr 3.66TCr 3.41TCr 3.09TCr 5.82TCr 3,89100Cr 5.87TCr 41TCr 16TCr 2,02400Cr 15TCr 15TCr 6,49300Cr | P/E 2026 * |
35.2x | P/E 2027 * | 31.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4.14TCr 3.69TCr 3.44TCr 3.12TCr 5.88TCr 3,92600Cr 5.92TCr 41TCr 16TCr 2,04200Cr 16TCr 15TCr 6,55200Cr | EV / Sales 2026 * |
8.76x | EV / Sales 2027 * | 7.96x |
| Free-Float |
72.37% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IDXX | Delayed | |
CBOE
| IDXX | Real-time | |
|
Mexican S.E.
| IDXX * | End-of-day quote | |
|
London S.E.
| 0J8P | Delayed | |
|
Tradegate
| IX1 | Real-time | |
|
Boerse Muenchen
| IX1 | Real-time | |
|
Deutsche Boerse AG
| IX1 | Delayed | |
|
Wiener Boerse
| IDXX | End-of-day quote | |
|
Börse Stuttgart
| IX1 | Delayed | |
|
Xetra
| IX1 | Delayed | |
|
Berne S.E.
| IX1 | End-of-day quote | |
|
Borsa Italiana
| 1IDXX | End-of-day quote |
Last Transcript: IDEXX Laboratories, Inc.
| 1 day | -0.69% | ||
| 1 week | +0.95% | ||
| Current month | -0.36% | ||
| 1 month | +3.09% | ||
| 3 months | -7.78% | ||
| 6 months | -9.35% | ||
| Current year | -23.09% |
| 1 week | 506.12 |  | 528.48 |
| 1 month | 501.17 | | 536.84 |
| Current year | 500.61 | | 726.41 |
| 1 year | 500.61 | | 769.98 |
| 3 years | 356.14 | | 769.98 |
| 5 years | 317.06 | | 769.98 |
| 10 years | 102.45 | | 769.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Erickson
CEO | Chief Executive Officer | 52 | 12/05/2026 |
Andrew Emerson
DFI | Director of Finance/CFO | 43 | 01/03/2025 |
Martin Smith
COO | Chief Operating Officer | 58 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 12/05/2026 | |
| Director/Board Member | 64 | 15/07/2013 | |
Daniel Junius
BRD | Director/Board Member | 73 | 11/03/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/09/26 | Exercice | Director | 6,609 | 0.0084% | ||
| 20/08/26 | Exercice | Chief Financial Officer | 616 | 0.0008% | ||
| 30/07/26 | Free | Director | 49 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.69% | +0.95% | -17.84% | +22.09% | 4.1TCr | |
| +0.78% | +4.53% | -21.90% | +12.92% | 18TCr | |
| +1.17% | +6.80% | -2.69% | +29.25% | 12TCr | |
| -0.02% | +1.56% | -22.57% | +9.57% | 11TCr | |
| +2.39% | +1.94% | -45.08% | -9.73% | 7.53TCr | |
| +1.55% | +4.34% | +4.14% | +74.68% | 6.3TCr | |
| +0.34% | +1.05% | +19.75% | +67.00% | 5.35TCr | |
| -0.80% | +3.92% | +0.38% | -27.57% | 5.1TCr | |
| -1.00% | +2.00% | +30.46% | +11.64% | 3.21TCr | |
| -0.17% | +0.42% | - | - | 3.13TCr | |
| Average | +0.33% | +2.32% | -6.15% | +21.09% | 7.52TCr | |
| Weighted average by Cap. | +0.60% | +3.04% | -11.74% | +19.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 472.2Cr 421.82Cr 393.17Cr 356.45Cr 670.82Cr 45TCr 676.09Cr 4.71TCr 1.84TCr 23TCr 1.77TCr 1.73TCr 75TCr | 513.92Cr 459.08Cr 427.9Cr 387.95Cr 730.09Cr 49TCr 735.83Cr 5.13TCr 2.01TCr 25TCr 1.93TCr 1.89TCr 81TCr |
| Net income | 117.82Cr 105.25Cr 98Cr 89Cr 167.39Cr 11TCr 168.7Cr 1.18TCr 460.07Cr 5.82TCr 442.5Cr 432.79Cr 19TCr | 131.3Cr 117.29Cr 109.33Cr 99Cr 186.53Cr 12TCr 188Cr 1.31TCr 512.7Cr 6.48TCr 493.12Cr 482.3Cr 21TCr |
| Net Debt | 37Cr 33Cr 31Cr 28Cr 52Cr 3.49TCr 53Cr 367.05Cr 143.69Cr 1.82TCr 138.2Cr 135.17Cr 5.83TCr | -9.73Cr -8.7Cr -8.1Cr -7.35Cr -14Cr -923.96Cr -14Cr -97Cr -38Cr -480.53Cr -37Cr -36Cr -1.54TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $520.31 | -0.69% | 4,45,415 |
| 12/26/12 | $523.94 | +1.15% | 5,52,787 |
| 09/26/09 | $518.00 | +0.95% | 4,66,778 |
| 08/26/08 | $513.14 | +1.28% | 6,96,677 |
| 07/26/07 | $506.67 | -1.70% | 7,16,449 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IDXX Stock
Select your edition
All financial news and data tailored to specific country editions
